FDA — authorised 19 June 1995
- Status: approved
🇺🇸 Dirythromycin in United States
FDA authorised Dirythromycin on 19 June 1995
Marketing authorisations
FDA — authorised 19 June 1995
- Application: NDA050678
- Marketing authorisation holder: LILLY RES LABS
- Local brand name: DYNABAC
- Indication: TABLET, DELAYED RELEASE — ORAL
- Status: approved
Dirythromycin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Dirythromycin approved in United States?
Yes. FDA authorised it on 19 June 1995; FDA authorised it on 19 June 1995.
Who is the marketing authorisation holder for Dirythromycin in United States?
Marketing authorisation holder not available in our data.